Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | Bromomethylcyclopropane | HCID 81503 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 53887943 | HCID 53887943 | — |
| Product | HCID 67713528 | HCID 67713528 | 38% |
Reaction Steps
4.6 g (12.9 mmol) of (S)-1-(3-aminomethyl-1,2,4-oxadiazol-5-yl)-8-chloro-12,12a-dihydro-9H,11H-azeto[2,1-c]-imidazo[1,5-a][1,4]benzodiazepin-9-one, 25 ml of N,N-dimethylformamide, 8.6 ml (50.3 mmol) of N-ethyldiisopropylamine and 3.4 ml (32.2 mmol) of bromomethylcyclopropane were stirred at 80° for 18 hours. The reaction solution was evaporated, the residue was dissolved in methylene chloride, the solution was washed three times with water, dried over magnesium sulfate and evaporated. The residue was chromatographed on 110 g of silica gel while eluting with methylene chloride/ethyl acetate 1/1. There were obtained 2.3 g (38%) of (S)-1-[3-(bis-cyclopropylmethylaminomethyl)-1,2,4-oxadiazol-5-yl]-8-chloro-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one, which was converted into the hydrochloride of m.p. 155°-160°.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05665718 |
|---|
| Source dataset | uspto-grants-1997_09 |
|---|
| ORD ID | ord-09fc0db92b78438dad5711c5bbf8e71b |
|---|
| Source note | uspto-grants-1997_09 |
|---|